Where you are


Infond Life, equity subfund of Infond Umbrella fund invests mainly in the shares of sectorally limited portfolios of companies from the Healthcare sector (Pharmaceuticals and biotechnology, medical equipment industry, service providers e.g. wholesalers, laboratory services and companies operating hospitals, care homes and homes for the elderly…).

 

Basic information
About
Monthly report
FUND PERFOR- MANCE ASSET ALLOCATION GEOGRAPHICAL ALLOCATION SECTOR ALLOCATION TOP 10
  • Performance
    Custom graph
  • Stocks82.53%82.53%
    Open-end investment funds9.09%9.09%


    As at: 30.04.2013
  • USA57.25%57.25%
    Switzerland9.15%9.15%
    Germany4.61%4.61%
    France4.24%4.24%
    Great Britain3.84%3.84%
    Denmark2.64%2.64%
    Israel1.47%1.47%
    Ireland1.28%1.28%
    Mexico1.10%1.10%
    Other6.03%6.03%


    As at: 30.04.2013
  • Brand name drugs37.93%37.93%
    Biotechnology18.57%18.57%
    Generic drugs15.56%15.56%
    Medical services11.44%11.44%
    Medical products8.11%8.11%


    As at: 30.04.2013
  • ROCHE HOLDING4.67%
    JOHNSON&JOHNSON4.57%
    PFIZER4.28%
    NOVARTIS3.93%
    SANOFI3.71%
    MERCK & CO3.05%
    NOVO NORDISK2.64%
    GLAXOSMITHKLINE2.46%
    BAYER2.35%
    MYLAN2.29%


    As at: 30.04.2013
Data for 16.05.2013
NAV (EUR) 18.58 EUR NAV (EUR)
DAILY %-0.90%*Padec
1 Yr 31.62% *Dvig
3 Yr 45.86% *Dvig
Ongoing Charge
01.01.2012 - 31.12.2012		 2.17%
Ongoing Charge Archive
Comparison table for all funds
Nova KBM
KBM Infond, družba za upravljanje d.o.o. - Skupina Nove KBM, Vita Kraigherja 5, 2000 Maribor T: 02 229 2080 (080 22 42) F: 02 229 2796 info@infond.si; Matična številka: 5822416; družba je vpisana v sodni register Okrožnega sodišča v Mariboru; znesek vpisanega in vplačanega osnovnega kapitala je 1.460.524,00 EUR